Miltefosine presents new hope for leishmaniasis patients.
Paterson
Rachael
R
D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D006078:Government Programs; D006801:Humans; D007194:India; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D010767:Phosphorylcholine / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D000981:Antiprotozoal Agents; D010767:Phosphorylcholine; C039128:miltefosine